Parathyroid hormone-related peptide is a regulatory protein implicated in the pathogenesis of bone metastases, particularly in breast carcinoma. Parathyroid hormone-related peptide is widely expressed ...

A HYPOPARATHYROID subject acquired resistance to the effects of parathyroid extract (parathyroid, U.S.P.) during treatment. Resistance developed in association with specific antibody detected as gamma ...

Parathyroid hormone levels in older women remained within the normal reference range as women aged, even with parathyroid hormone increases of up to 50% above baseline, researchers in Sweden reported.

Background: Human parathyroid hormone (hPTH)(1–34) was approved in 2004 for the treatment of severe osteoporosis. Members of the Osteoporosis Canada clinical guidelines committee conducted a ...

Researchers led by Prof. YANG Fan from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences and their collaborators have proposed a new approach to control ...

Hypoparathyroidism, a rare and chronic endocrine disease, is characterized by insufficient levels of parathyroid hormone (PTH ...

Parathyroid cancer is very rare. Most cases of parathyroid disease, including almost all cases of overactive parathyroid, are not cancer. At Fred Hutchinson Cancer Center, our endocrine tumor ...

Please provide your email address to receive an email when new articles are posted on . At 52 weeks, 81% of adults receiving palopegteriparatide had normalized serum calcium levels without needing ...